Glucose-dependent insulinotropic polypeptide: difference between revisions
Diff·revision 5 → 6·10:46, 11 Aug 2024
Difference between revision 5 and revision 6 of Glucose-dependent insulinotropic polypeptide. 5 lines changed; the page grew by 149 bytes.
| Revision 5 — 01:00, 27 Jul 2024 StubSorterBot (talk) bot: flag bare reference 3,368 bytes +817 | Revision 6 — 10:46, 11 Aug 2024 LCellLeif (talk) the numbers in the lead disagreed with the body; body was right 3,517 bytes +149 | ||
|---|---|---|---|
| 4 | | Precursor = [[Proglucagon|Pro-GIP]] (gene {{math|GIP}}) | 4 | | Precursor = [[Proglucagon|Pro-GIP]] (gene {{math|GIP}}) |
| 5 | | Principal source = Intestinal K cells (duodenum, proximal jejunum) | 5 | | Principal source = Intestinal K cells (duodenum, proximal jejunum) |
| + | 6 | <!-- Molecular data --> | |
| + | 7 | | Residues = 42 | |
| + | 8 | | Monoisotopic mass = ≈4,972 Da | |
| + | 9 | | Plasma half-life = 7 minutes | |
| 6 | }} | 10 | }} |
| 7 | 11 | ||
| ⋮ | ⋮ | ||
| 26 | [[Category:Incretin biology]] | 30 | [[Category:Incretin biology]] |
| 27 | [[Category:Peptide drugs]] | 31 | [[Category:Peptide drugs]] |
| + | 32 | [[Category:Gastrointestinal physiology]] | |
| 28 | 33 |